Cargando…
Therapeutic Effects of Biobran, Modified Arabinoxylan Rice Bran, in Improving Symptoms of Diarrhea Predominant or Mixed Type Irritable Bowel Syndrome: A Pilot, Randomized Controlled Study
Background. Recently, it was revealed that low grade mucosal inflammation and/or immune imbalance of the lower digestive tract is one of the mechanisms involved in symptom generation in patients with irritable bowel syndrome (IBS). Biobran, arabinoxylan compound derived from rice bran, has been repo...
Autores principales: | Kamiya, Takeshi, Shikano, Michiko, Tanaka, Mamoru, Ozeki, Keiji, Ebi, Masahide, Katano, Takahito, Hamano, Shingo, Nishiwaki, Hirotaka, Tsukamoto, Hironobu, Mizoshita, Tsutomu, Mori, Yoshinori, Kubota, Eiji, Tanida, Satoshi, Kataoka, Hiromi, Okuda, Noriaki, Joh, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139075/ https://www.ncbi.nlm.nih.gov/pubmed/25161692 http://dx.doi.org/10.1155/2014/828137 |
Ejemplares similares
-
Adalimumab Treatment in Biologically Naïve Crohn's Disease: Relationship with Ectopic MUC5AC Expression and Endoscopic Improvement
por: Mizoshita, Tsutomu, et al.
Publicado: (2014) -
Colon Mucosa Exhibits Loss of Ectopic MUC5AC Expression in Patients with Ulcerative Colitis Treated with Oral Tacrolimus
por: Mizoshita, Tsutomu, et al.
Publicado: (2013) -
Managing refractory Crohn’s disease: challenges and solutions
por: Tanida, Satoshi, et al.
Publicado: (2015) -
Combination Therapy with Intensive Granulocyte and Monocyte Adsorptive Apheresis plus Adalimumab: Therapeutic Outcomes in 5 Cases with Refractory Crohn's Disease
por: Ozeki, Keiji, et al.
Publicado: (2012) -
Arabinoxylan rice bran (MGN-3/Biobran) enhances radiotherapy in animals bearing Ehrlich ascites carcinoma(†)
por: Badr El-Din, Nariman K, et al.
Publicado: (2019)